Kerendia® (finerenone)
for Kidney Disease

Kerendia (finerenone) is an FDA-approved oral medication for adults with chronic kidney disease (CKD) caused by type 2 diabetes. It helps slow kidney damage and lowers the risk of kidney failure, cardiovascular death, heart attack, and heart failure hospitalization. As a mineralocorticoid receptor antagonist, Kerendia reduces excess sodium, fibrosis, and inflammation in the kidneys, heart, and blood vessels.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Kidney Disease